-+ 0.00%
-+ 0.00%
-+ 0.00%

Leerink Partners Maintains Market Perform on PROCEPT BioRobotics, Raises Price Target to $22

Benzinga·11/05/2026 20:03:40
Listen to the news
Leerink Partners analyst Mike Kratky maintains PROCEPT BioRobotics (NASDAQ:PRCT) with a Market Perform and raises the price target from $20 to $22.